首页> 美国卫生研究院文献>other >WHITE MATTER DAMAGE AFTER TRAUMATIC BRAIN INJURY: A ROLE FOR DAMAGE ASSOCIATED MOLECULAR PATTERNS
【2h】

WHITE MATTER DAMAGE AFTER TRAUMATIC BRAIN INJURY: A ROLE FOR DAMAGE ASSOCIATED MOLECULAR PATTERNS

机译:创伤性脑损伤后的白色物质损伤:与分子相关损伤的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Traumatic brain injury (TBI) is a leading cause of mortality and long-term morbidity worldwide. Despite decades of pre-clinical investigation, therapeutic strategies focused on acute neuroprotection failed to improve TBI outcomes. This lack of translational success has necessitated a reassessment of the optimal targets for intervention, including a heightened focus on secondary injury mechanisms. Chronic immune activation correlates with progressive neurodegeneration for decades after TBI; however, significant challenges remain in functionally and mechanistically defining immune activation after TBI. In this review, we explore the burgeoning evidence implicating the acute release of damage associated molecular patterns (DAMPs), such as adenosine 5′-triphosphate (ATP), high mobility group box protein 1 (HMGB1), S100 proteins, and hyaluronic acid in the initiation of progressive neurological injury, including white matter loss after TBI. The role that pattern recognition receptors, including toll-like receptor and purinergic receptors, play in progressive neurological injury after TBI is detailed. Finally, we provide support for the notion that resident and infiltrating macrophages are critical cellular targets linking acute DAMP release with adaptive immune responses and chronic injury after TBI. The therapeutic potential of targeting DAMPs and barriers to clinical translational, in the context of TBI patient management, are discussed.
机译:颅脑外伤(TBI)是全球范围内死亡率和长期发病率的主要原因。尽管进行了数十年的临床前研究,但针对急性神经保护作用的治疗策略未能改善TBI结局。由于缺乏翻译成功,因此有必要重新评估最佳干预目标,包括更加关注继发性损伤机制。 TBI后数十年,慢性免疫激活与进行性神经变性相关。然而,在TBI后定义免疫激活的功能和机制上仍然存在重大挑战。在这篇综述中,我们探讨了涉及损伤相关分子模式(DAMP)的急性释放的新兴证据,这些分子模式包括腺苷5'-三磷酸(ATP),高迁移率基盒蛋白1(HMGB1),S100蛋白和透明质酸。开始进行性神经损伤,包括TBI后白质丢失。详细介绍了模式识别受体(包括通行费受体和嘌呤能受体)在TBI后进行性神经损伤中的作用。最后,我们为常住和浸润的巨噬细胞是将急性DAMP释放与适应性免疫反应和TBI后的慢性损伤联系起来的关键细胞靶点提供了支持。在TBI患者管理的背景下,讨论了靶向DAMPs和临床转化障碍的治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号